New technologies for personalized and precision medicine

Personalized and precision medicine aim to revolutionize healthcare by utilizing diverse information sources for actionable health management. They involve tracking individuals' health over time to understand disease onset, better identifying at-risk individuals, and tailoring treatments based on comprehensive data. According to Singaporean researchers, precision medicine has yielded significant insights into disease mechanisms, therapeutic targets, and treatment response biomarkers, leading to improved patient outcomes.
However, a significant challenge lies in effectively assessing treatment outcomes due to limited biomarkers, especially in conditions like solid cancers, tuberculosis, pain, and brain injury. Emerging technologies offer promise for more frequent and precise biomarker surveillance compared to conventional methods like imaging or blood tests. Gene editing tools such as CRISPR and zinc finger nucleases present opportunities for precise genome alterations, potentially transforming treatments for various conditions from cancer to HIV. Another important method like individualized drug dosing and parameters, crucial for conditions like pulmonary hypertension and cancer therapy, require continuous and robust monitoring. Wearable technology, for example, is poised to facilitate personalized therapy by enabling ongoing patient monitoring. Additionally, the recent approval of chimeric antigen receptor-T (CAR-T) cell immunotherapy marks a significant milestone in personalized cancer treatment.
The widespread adoption of precision and personalized medicine hinges on advancements in interdisciplinary education, supportive policies for innovative clinical trials, and the widespread use of electronic medical records (EMR) for informed clinical decision-making. This integrated approach holds promise for a healthcare paradigm tailored to individual needs.